Home » Bristol-Myers, Osuka Get FDA OK for Abilify as Add-On Depression Treatment
Bristol-Myers, Osuka Get FDA OK for Abilify as Add-On Depression Treatment
Bristol-Myers Squibb Tuesday said it and partner Osuka Pharmaceutical Co. have received approval of a supplemental new drug application for the use of Abilify as an add-on treatment for depression from the Food and Drug Administration.
CNN Money
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May